Advertisement

Table of contents

  1. Front Matter
    Pages I-IX
  2. H. Hippius, P. Hoff, K. Münch
    Pages 1-6
  3. M. M. Weissman, J. K. Myers, P. J. Leaf, G. L. Tischler, C. E. Holzer
    Pages 16-25
  4. H. Katschnig, D. Nutzinger, H. Schanda
    Pages 36-44
  5. R. M. A. Hirschfeld
    Pages 45-52
  6. E. S. Gershon, J. I. Nürnberger, N. Sitaram
    Pages 79-89
  7. M. R. Liebowitz, F. M. Quitkin, J. W. Stewart, P. J. McGrath, W. Harrison, J. Rabkin et al.
    Pages 112-117
  8. D. J. Kupfer, E. Frank, J. M. Perel
    Pages 118-125
  9. W. Greil, M. Haag, D. van Calker
    Pages 131-144
  10. M. Åsberg, B. MÅrtensson, A. WÄgner
    Pages 156-168
  11. L. J. Siever, E. F. Coccaro, F. Adan, R. C. Mohs, K. L. Davis
    Pages 189-195
  12. D. von Zerssen, M. Berger, P. Doerr, C. Lauer, C. Krieg, K.-M. Pirke
    Pages 205-216
  13. G. Laakmann, A. Hinz, E. Neulinger
    Pages 250-260
  14. Back Matter
    Pages 261-263

About these proceedings

Introduction

The improvements in treatment for depression as reviewed here are based on: 1. New developments in the realm of antidepressive medication, involving the use of second-generation antidepressants; treatment with precursors; new forms of treatment by intravenous drip infusion; and a new approach to long-term pro­ phylactic therapy entailing administration of an anti-epileptic agent. 2. Improved psychotherapeutic procedures employed as an accompaniment to antidepressive medication; correction of errors liable to be committed in the conduct of psychotherapy; clarification of the indications for group, family, or behavioral therapy and psychoanalysis. New psychotherapeutic methods allow conversational therapy to be more closely adapted to the patient's indi­ vidual needs and render it more effective. 3. New findings relating to diagnosis and monitoring of the clinical course with the help of biological markers. Although no specific markers have yet been dis­ covered, the markers now available do make it possible to establish a more ac­ curate differential diagnosis of the various types of depression. Moreover, in individual cases of depression, the response to treatment can often be more sat­ isfactorily monitored by resorting to state-dependent markers. A clear-cut biological classification of depressive states would in certain types of depression make it feasible in the near future to administer substitution treat­ ment with precursors and later possibly even to provide causal therapy. Discussion In supplement to this comprehensive survey, findings were reported which may support the hypothesis that the cortisol escape after dexamethasone could be a trait variable.

Keywords

depression diagnosis psychoanalysis research therapy

Editors and affiliations

  • Hanns Hippius
    • 1
  • Gerald L. Klerman
    • 2
  • Norbert Matussek
    • 3
  1. 1.Psychiatrische Klinik und Poliklinik der Universität MünchenMünchen 2Germany
  2. 2.Department of PsychiatryCornell University Medical SchoolWhite PlainsUSA
  3. 3.Psychiatrische Klinik der Universität MünchenMünchen 2Germany

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-642-70702-5
  • Copyright Information Springer-Verlag Berlin Heidelberg 1986
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-540-15782-3
  • Online ISBN 978-3-642-70702-5
  • Buy this book on publisher's site